NVAX Jul 2024 17.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:43AM EDT. Market open.
| Previous close | 0.5400 |
| Open | 0.5700 |
| Bid | 0.3800 |
| Ask | 0.5300 |
| Strike | 17.00 |
| Expiry date | 2024-07-12 |
| Day's range | 0.5000 - 0.5700 |
| Contract range | N/A |
| Volume | |
| Open interest | 84 |
GuruFocus.comInsider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
On June 18, 2024, James Young, Director at Novavax Inc (NASDAQ:NVAX), executed a sale of 7,500 shares of the company. Following this transaction, the insider now owns 69,260 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.
Investor's Business DailyThe FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?
ZacksNovavax (NVAX) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Novavax (NVAX) closed at $14.06, indicating a +1.99% shift from the previous trading day.
© 2024 Yahoo. All rights reserved.